QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 on-july-29-ontrak-board-decides-to-cease-operations-terminates-employment-of-executive-officers-to-terminate-all-employees-on-july-31-2025

-SEC Filing

 roth-capital-maintains-buy-on-ontrak-lowers-price-target-to-3

Roth Capital analyst Jonathan Aschoff maintains Ontrak (NASDAQ:OTRK) with a Buy and lowers the price target from $4 to $3.

 ontrak-sees-q2-sales-2200m-2600m-vs-375m-est

Ontrak (NASDAQ:OTRK) sees Q2 sales of $2.200 million-$2.600 million vs $3.75 million analyst estimate.

 ontrak-q1-adj-eps-140-misses-124-estimate-sales-200m-miss-340m-estimate

Ontrak (NASDAQ:OTRK) reported quarterly losses of $(1.40) per share which missed the analyst consensus estimate of $(1.24) by 1...

 ontrak-secures-10m-financing-commitment-from-acuitas-capital-to-fuel-growth-expand-customer-base-and-advance-ai-powered-behavioral-healthcare-solutions-with-potential-for-additional-third-party-funding

Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement techno...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION